Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05130606

CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing

This is a mixed-methods Hybrid Type 1 research design (efficacy study) in which we aim to conduct a two-arm randomized controlled trial and an Implementation Focused Process Evaluation of a culturally-targeted video and referral screening tool.

In this study, the investigators aim to evaluate the efficacy of a culturally targeted video previously developed by the research team vs. a Spanish-language fact sheet from an established group on enhancing genetic counseling and testing uptake and psychosocial outcomes in Latina women at risk for hereditary breast and ovarian cancer.

The investigators will test the video's efficacy while also gathering data on the implementation and future sustainability of using the Risk Screening Tool (RST) and video in community clinics.

Recruiting

Interested in participating?

Request Info

Key information

About this study

The investigators previously developed and piloted a culturally targeted narrative video in Spanish to provide HBOC and GCT education to at-risk Latinas. The investigators expanded traditional approaches to address psychosocial barriers through risk messages designed to elicit emotional responses; emotions are often stronger predictors of behavior than cognition. Our video is responsive to Latinas' preferences, targets motivators, and addresses psychosocial barriers identified in our formative research.

In this study, the investigators aim to evaluate the efficacy of our video vs. a fact sheet from an established group on enhancing GCT uptake and psychosocial outcomes on a two-arm randomized controlled trial. The investigators will test the video's efficacy while also gathering data on the implementation and future sustainability of using an adapted Risk Screening Tool (RST) and video in community clinics.

The investigators will partner with community clinics and implement a Risk Screening Tool (RST) at their practice to identify women at risk of HBOC. Community clinic staff (N~32) will be asked to participate in a pre-implementation and a post-implementation focus group to assess implementation outcomes of integrating HBOC screening practices in their clinic. Through the community clinics, the investigators aim to recruit N~300 Latina women at risk for HBOC based on their personal or family history of cancer. Latina women at risk for HBOC will be randomized to a Video arm or Fact Sheet Arm. All participants in the randomized controlled trial will be offered genetic counseling and testing.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Aim 1 and 2.

  • Self-identify as a Latina woman
  • Be 18 years old or older
  • Be able to provide informed consent
  • Be fluent in Spanish
  • Meet NCCN criteria to be considered for genetic cancer risk assessment for HBOC, whether by a personal history of cancer or family history of cancer
  • No previous participation in genetic counseling or testing for hereditary breast and ovarian cancer risk
  • No other family members are participating in this study
  • Have not participated in any previous studies involving interventions about HBOC or GCT

Aim 3.

  • Be 18 years old or older
  • Be fluent in English or Spanish
  • Have a role in the partner community clinic as either a) full-time or part-time employee b) intern c) volunteer

Exclusion criteria

-

Treatment and study plan

Culturally Targeted Narrative Video: "Is My Cancer Hereditary? Rosa Visits a Genetic Counselor."

Behavioral

Participants randomized to the video arm will receive a link with a password by email or text message to watch the video, depending on participants' preference. Participants without internet access will receive a DVD. Participants will be instructed to watch the video alone with no interruptions. We will ask them not to share the link with others.

FORCE Fact Sheet

Behavioral

Participants will receive a PDF of the fact sheet by email, text message, or a printed fact sheet by mail depending on participants' preferences. The fact sheet includes information about genes, breast cancer, risk factors for HBOC, genetic counseling and testing, and resources.

Primary outcomes

  1. Uptake of Genetic Counseling

    Time frame: Change from the baseline survey to four months after baseline

    Participants will self report whether they attended a genetic counseling session in the four months following their baseline survey. The study team will also have direct access to the genetic counseling company's records.

  2. Uptake of Genetic Testing

    Time frame: Change from the baseline survey to four months after baseline

    Participants will self report whether they completed a genetic test for hereditary cancer in the four months following their baseline survey. The study team will also have direct access to the genetic counseling company's records.

Secondary outcomes

  1. Knowledge about HBOC

    Time frame: Change from the baseline to two-week after baseline, and change from two-week follow up survey to four months after baseline

    9-item Scale from Kasting et al, 2019. The scale has statements to which participants respond True, False, or I don't Know. The scale is scored based on the accuracy of responses. A higher score indicates higher knowledge. Scores range from 0-9.

  2. Self-efficacy about attending genetic cancer risk assessment

    Time frame: Change from the baseline to two-week after baseline

    Change in self-efficacy about genetic counseling and testing will be measured by specific items from the Theory of Planned Behavior scale (Ajzen, 2002) on a scale from 1-7 -Not at all to 7- Extremely)

  3. Beliefs and Attitudes about genetic cancer risk assessment

    Time frame: Change from the baseline to two-week after baseline

    Changes in beliefs and attitudes about genetic counseling and genetic testing. The outcome will be assessed by 22 items from a scale developed by Sussner, Jandorf, Thompson et al., 2012 in which participants respond to a Likert-type scale from 1 (completely disagree) to 7 (completely agree).

  4. Subjective norms about genetic cancer risk assessment

    Time frame: Change from the baseline to two-week after baseline

    Change in subjective norms about genetic counseling and testing will be measured by specific items from the Theory of Planned Behavior scale (Ajzen, 2002) on a scale from 1-Not at all to 7- Extremely)

  5. Anticipatory emotions about genetic cancer risk assessment

    Time frame: Change from the baseline to two-week after baseline

    Scale items on a 7-point Likert-type response (from 1-strongly disagree to 7-strongly agree).

  6. Acceptability of the intervention

    Time frame: At two weeks after baseline

    Overall acceptability is measured on a 4-item self-reported scale ranging from 1 to 10, where 1 = not at all to 10 = highly

  7. Feasibility of the intervention

    Time frame: At two weeks after baseline

    Proportion of women who have watched/read the video or fact sheet at the two week follow up

Other outcomes

  1. Feasibility of the Referral Screening Tool

    Time frame: Change from the pre-implementation focus groups with community clinics to post implementation focus groups with community clinics (48 months)

    Qualitative measure captured through semi-structured interviews using the Consolidated Framework for Implementation Research. (e.g., What barriers and facilitators did you experience while implementing the RST?)

  2. Acceptability of the Referral Screening Tool

    Time frame: Change from the pre-implementation focus groups with community clinics to post implementation focus groups with community clinics (48 months)

    Qualitative measure captured through semi-structured interviews using the Consolidated Framework for Implementation Research.

  3. Adoption of the Referral Screening Tool

    Time frame: At the post implementation focus groups with community clinics adoption over the previous 48 months will be assessed

    Qualitative measure captured through semi-structured interviews using the Consolidated Framework for Implementation Research.

  4. Sustainability of the Referral Screening Tool

    Time frame: At the post implementation focus groups with community clinics sustainability of the screener based on their experience during the previous 48 months will be assessed

    Qualitative measure captured through semi-structured interviews using the Consolidated Framework for Implementation Research.

Study contacts

Contact information is provided by the study sponsor or research team.

Alejandra Hurtado de Mendoza, Ph.D

CONTACT

[email protected]

2026878916

Sponsors and collaborators

Lead sponsor

Georgetown University

Other

Collaborators

  • National Cancer Institute (NCI)
  • Virginia Commonwealth University

Registry information

Official study title

Testing a Narrative Intervention to Enhance Genetic Counseling and Testing

Important dates

Study start
2021
Primary completion
2025
Study completion
2025
First posted
Nov 23, 2021
Registry last updated
Aug 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.